Discontinuation report IMOVANE
Report ID | 160688 |
Drug Identification Number | 02216167 |
Brand name | IMOVANE |
Common or Proper name | ZOPICLONE |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ZOPICLONE |
Strength(s) | 5.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | Bottle of 100 tablets |
ATC code | N05CF |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2022-05-31 |
Actual discontinuation date | |
Remaining supply date | 2022-05-31 |
Discontinuation status | To be discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2022-05-16 | French | Compare |
v2 | 2022-05-16 | English | Compare |
v1 | 2022-05-16 | English | Compare |
Showing 1 to 3 of 3